2010 Scrip 100 - Strengthening Bayer Schering Pharma's franchise selectively
09 December 2009
Ashley Yeo
A strong, late-stage pipeline, good penetration of emerging markets and a relatively low exposure in the US have made Bayer Schering Pharma one of the more interesting of the leading pharma companies to watch. Its CEO Andreas Fibig talked to Ashley Yeo.
It is late September...
Please Login to read the full article.
09 December 2009
Ashley Yeo
It is late September...
Please Login to read the full article.
RELATED CONTENT
NEWS
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- Actos suspension could shake up a market already in transition
- Asia Beat: How to feed your dragon
- Bayer expects €11bn group sales in Asia by 2015 but wants premium drug pricing in India
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
